Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Failure of traditional trough levels to predict tacrolimus concentrations.

Macchi-Andanson M, Charpiat B, Jelliffe RW, Ducerf C, Fourcade N, Baulieux J.

Ther Drug Monit. 2001 Apr;23(2):129-33.

PMID:
11294512
2.

A population pharmacokinetic model of cyclosporine in the early postoperative phase in patients with liver transplants, and its predictive performance with Bayesian fitting.

Charpiat B, Falconi I, Bréant V, Jelliffe RW, Sab JM, Ducerf C, Fourcade N, Thomasson A, Baulieux J.

Ther Drug Monit. 1998 Apr;20(2):158-64.

PMID:
9558129
3.
4.

Easy-to-use, accurate and flexible individualized Bayesian limited sampling method without fixed time points for ciclosporin monitoring after liver transplantation.

Langers P, Cremers SC, den Hartigh J, Rijnbeek EM, Ringers J, Lamers CB, van Hoek B.

Aliment Pharmacol Ther. 2005 Mar 1;21(5):549-57.

5.
6.

Pharmacokinetic modeling and development of Bayesian estimators in kidney transplant patients receiving the tacrolimus once-daily formulation.

Saint-Marcoux F, Debord J, Undre N, Rousseau A, Marquet P.

Ther Drug Monit. 2010 Apr;32(2):129-35. doi: 10.1097/FTD.0b013e3181cc70db.

PMID:
20110850
7.

Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients.

Lumlertgul D, Noppakun K, Rojanasthien N, Kanchanarattanakorn K, Jittikanont S, Manoyot A, Bunnachak D, Ophascharoensuk V.

J Med Assoc Thai. 2006 Aug;89 Suppl 2:S73-8.

PMID:
17044457
8.

Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus.

Staatz CE, Tett SE.

Eur J Clin Pharmacol. 2002 Dec;58(9):597-605. Epub 2002 Nov 15.

PMID:
12483452
9.

Population pharmacokinetics of tacrolimus in pediatric liver transplantation: early posttransplantation clearance.

Wallin JE, Bergstrand M, Wilczek HE, Nydert PS, Karlsson MO, Staatz CE.

Ther Drug Monit. 2011 Dec;33(6):663-72. doi: 10.1097/FTD.0b013e31823415cc.

PMID:
22105583
10.

Prospective evaluation of the bayesian method for individualizing tacrolimus dose early after living-donor liver transplantation.

Fukudo M, Yano I, Shinsako K, Katsura T, Takada Y, Uemoto S, Inui K.

J Clin Pharmacol. 2009 Jul;49(7):789-97. doi: 10.1177/0091270009333853. Epub 2009 Jun 1.

PMID:
19487492
11.

Population Pharmacokinetic Modelling and Bayesian Estimation of Tacrolimus Exposure: Is this Clinically Useful for Dosage Prediction Yet?

Brooks E, Tett SE, Isbel NM, Staatz CE.

Clin Pharmacokinet. 2016 Nov;55(11):1295-1335. Review.

PMID:
27138787
12.

Population pharmacokinetics of tacrolimus in pediatric hematopoietic stem cell transplant recipients: new initial dosage suggestions and a model-based dosage adjustment tool.

Wallin JE, Friberg LE, Fasth A, Staatz CE.

Ther Drug Monit. 2009 Aug;31(4):457-66. doi: 10.1097/FTD.0b013e3181aab02b.

PMID:
19531982
13.

Population pharmacokinetics of tacrolimus in adult kidney transplant recipients.

Staatz CE, Willis C, Taylor PJ, Tett SE.

Clin Pharmacol Ther. 2002 Dec;72(6):660-9.

PMID:
12496747
14.

Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.

Canadian Neoral Renal Transplantation Study Group.

Transplantation. 2001 Sep 27;72(6):1024-32.

PMID:
11579295
15.

Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients.

Fukudo M, Yano I, Masuda S, Goto M, Uesugi M, Katsura T, Ogura Y, Oike F, Takada Y, Egawa H, Uemoto S, Inui K.

Clin Pharmacol Ther. 2006 Oct;80(4):331-45.

PMID:
17015051
16.

Clotrimazole increases tacrolimus blood levels: a drug interaction in kidney transplant patients.

Vasquez E, Pollak R, Benedetti E.

Clin Transplant. 2001 Apr;15(2):95-9.

PMID:
11264634
17.

Optimal dose and target trough level in cyclosporine and tacrolimus conversion in renal transplantation as evaluated by lymphocyte drug sensitivity and pharmacokinetic parameters.

Takeuchi H, Okuyama K, Konno O, Jojima Y, Akashi I, Nakamura Y, Iwamoto H, Hama K, Iwahori T, Uchiyama M, Ashizawa T, Matsuno N, Nagao T, Hirano T, Oka K.

Transplant Proc. 2005 May;37(4):1745-7.

PMID:
15919452
18.

Evaluation of limited sampling strategies for tacrolimus.

Op den Buijsch RA, van de Plas A, Stolk LM, Christiaans MH, van Hooff JP, Undre NA, van Dieijen-Visser MP, Bekers O.

Eur J Clin Pharmacol. 2007 Nov;63(11):1039-44. Epub 2007 Aug 22.

19.

Nonparametric population modeling of valproate pharmacokinetics in epileptic patients using routine serum monitoring data: implications for dosage.

Bondareva IB, Jelliffe RW, Sokolov AV, Tischenkova IF.

J Clin Pharm Ther. 2004 Apr;29(2):105-20.

PMID:
15068399
20.

Flexible limited sampling model for monitoring tacrolimus in stable patients having undergone liver transplantation with samples 4 to 6 hours after dosing is superior to trough concentration.

Langers P, Press RR, den Hartigh J, Cremers SC, Baranski AG, Lamers CB, Hommes DW, van Hoek B.

Ther Drug Monit. 2008 Aug;30(4):456-61. doi: 10.1097/FTD.0b013e31818162b9.

PMID:
18641539

Supplemental Content

Support Center